3-[4-(4-(4-CYAN-PHENYL)-1-PIPERAZINYL)BUTYL]-5-CYAN-INDOL, USE THEREOF, METHOD OF ITS PREPARATION, PHARMACEUTICAL PREPARATION IT CONTAINING

3-[4-(4-(4-CYAN-PHENYL)-1-PIPERAZINYL)BUTYL]-5-CYAN-INDOL, USE THEREOF, METHOD OF ITS PREPARATION, PHARMACEUTICAL PREPARATION IT CONTAINING

Je opísaný 3-[4-(4-kyánfenyl)-1-piperazinyl)butyl]- -5-kyánindol a jeho adičné soli s kyselinami ako 5-hydroxytryptamínový agonista a antagonista pôsobiaci na centrálny nervový systém, je vhodný na výrobu farmaceutických prostriedkov.ŕ 3-((4-Phenylpiperazino)alkyl)-5-cyanoindole derivs. of formula (...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BUHRING KARL ULRICH, GREINER HARTMUT, BOTTCHER HENNING, SEYFRIED CHRISTOPH, BARTOSZYK GERD
Format: Patent
Sprache:eng ; slo
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Je opísaný 3-[4-(4-kyánfenyl)-1-piperazinyl)butyl]- -5-kyánindol a jeho adičné soli s kyselinami ako 5-hydroxytryptamínový agonista a antagonista pôsobiaci na centrálny nervový systém, je vhodný na výrobu farmaceutických prostriedkov.ŕ 3-((4-Phenylpiperazino)alkyl)-5-cyanoindole derivs. of formula (I) and their acid addn. salts are new. Ar = phenyl substd. by 1 or 2 CN and/or F; Q = CnH2n; n = 3 or 4; provided that 3-(4-(4-(4- fluorophenyl)-1-piperazinyl)butyl)-5-cyanoindole (I') and 3-(4-(4-(2-fluorophenyl)-1-piperazinyl)butyl)-5-cyanoindole (I"), but not their acid addn. salts, are excluded.